FDA label

What is Lumigan used for?

Lumigan contains bimatoprost. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.

Source: DailyMed SPL label file dated 2026-10-23. Publisher page

The FDA label says: “LUMIGAN ® (bimatoprost ophthalmic solution) 0.01% is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.”

Run it in Rivvi

Which 2027 plans near you dropped or restricted Lumigan?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Lumigan, solution/ drops

Indications and Usage, quoted from the label by Allergan, Inc. (NDA022184). Cross-references to other label sections are left out.

LUMIGAN ® (bimatoprost ophthalmic solution) 0.01% is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.

Source: DailyMed label, set id a5e67c75-db88-4372-bb07-c8dd15c97631, version 19, effective June 22, 2024. NDC 0023-3205, one of 1 listing for this product.

Questions

What is Lumigan used for?

The FDA label says: “LUMIGAN ® (bimatoprost ophthalmic solution) 0.01% is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.”

What drug class is Lumigan?

FDA lists bimatoprost in the Prostaglandin Analog established pharmacologic class.

Does this page cover off-label uses or dosing?

No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.

More on Lumigan

Try it on your own data today.

Free to start. Most teams are using it the same day.